Clinical Trial Update: Bone Mesenchymal Stem Cell (BMSC) Transplantation in Liver Cirrhosis Via Portal Vein [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating transplantation of bone mesenchymal stem cells via the portal vein for liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Bone mesenchymal stem cells (mesenchymal stem cell)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Liver Cirrhosis | Phase 2 | Status: UNKNOWN